Puca Pierluigi, Del Gaudio Angelo, Becherucci Guia, Sacchetti Franco, Sofo Luigi, Lopetuso Loris Riccardo, Papa Alfredo, Cammarota Giovanni, Scaldaferri Franco
IBD Unit, UOC CEMAD Centro Malattie dell'Apparato Digerente, Dipartimento di Scienze Mediche e Chirurgiche Addominali ed Endocrino Metaboliche, Fondazione Policlinico Universitario Agostino Gemelli IRCCS, 00168 Rome, Italy.
Dipartimento di Medicina e Chirurgia Traslazionale, Università Cattolica del Sacro Cuore, 00168 Rome, Italy.
Nutrients. 2024 Dec 16;16(24):4337. doi: 10.3390/nu16244337.
Chronic pouchitis occurs in about 50% of patients undergoing a restorative proctocolectomy for ulcerative colitis. This affection represents a significant therapeutic challenge, particularly for symptomatic patients who do not respond to antibiotic treatments and biologic therapies. Several dietary approaches, including low FODMAP diets and the Mediterranean diet, have shown promising results in improving symptoms and disease burden. The rationale for dietary intervention lies in the reduction in inflammation and modulation of gut microbiota. However, conflicting results and methodological heterogeneity jeopardize the transition of these approaches from the field of research to clinical practice. Together with a nutritional approach, innovative methods of microbiota modulation, including probiotics and fecal microbiota transplantation, are emerging as safe and effective strategies in managing chronic pouchitis. This narrative review analyzes recent advancements in nutritional therapies and microbiota modulation as innovative and complementary approaches for managing chronic pouchitis. After examining microbiota modulation strategies, specifically the effectiveness of probiotics, prebiotics, and fecal microbiota transplantation in restoring microbial diversity and their potential role in alleviating symptoms, the review assesses the available clinical evidence concerning dietary interventions and their impact on gut microbiota. A comprehensive understanding of interventions aimed at modulating the microbiota is crucial for enhancing the effectiveness of conventional therapies. Such strategies may lead to significant improvements in patients' quality of life and their perception of the disease. However, the variability in microbiota composition, the use of restrictive diets, and the lack of standardized methods for evaluating these interventions remain significant challenges. Future research is essential to improve our understanding of the underlying mechanisms and optimize clinical application.
约50%接受溃疡性结肠炎全直肠系膜切除回肠储袋肛管吻合术的患者会发生慢性储袋炎。这种病症是一个重大的治疗挑战,尤其是对于对抗生素治疗和生物治疗无反应的有症状患者。包括低FODMAP饮食和地中海饮食在内的几种饮食方法,在改善症状和疾病负担方面已显示出有前景的结果。饮食干预的基本原理在于减轻炎症和调节肠道微生物群。然而,相互矛盾的结果和方法学的异质性阻碍了这些方法从研究领域向临床实践的转化。与营养方法一起,包括益生菌和粪便微生物群移植在内的创新微生物群调节方法,正在成为管理慢性储袋炎的安全有效策略。这篇叙述性综述分析了营养疗法和微生物群调节方面的最新进展,将其作为管理慢性储袋炎的创新和补充方法。在研究了微生物群调节策略,特别是益生菌、益生元以及粪便微生物群移植在恢复微生物多样性方面的有效性及其在缓解症状方面的潜在作用后,该综述评估了关于饮食干预及其对肠道微生物群影响的现有临床证据。全面了解旨在调节微生物群的干预措施对于提高传统疗法的有效性至关重要。此类策略可能会显著改善患者的生活质量及其对疾病的认知。然而,微生物群组成的变异性、限制性饮食的使用以及评估这些干预措施缺乏标准化方法,仍然是重大挑战。未来的研究对于增进我们对潜在机制的理解和优化临床应用至关重要。